Infographics - Autism Spectrum Disorder Therapeutics Market

Autism, scientifically referred as Autism Spectrum Disorder Therapeutics (ASD) is a complex neurological disorder that is characterized by symptoms including challenges with social skills, repetitive behaviours, as well as issues with speech and non-verbal communication. Major companies operating in the ASD therapeutics market are focusing on extensive research & development and clinical trials to introduce new drugs. For instance, in February 2019, Servier Laboratories Ltd. and Neurochlore announced the launch of phase 3 studies to evaluate the use of Bumetanide in children with ASD. Bumetanide is typically used to treat fluid retention (edema) and high blood pressure.

Market Dynamics

Increasing prevalence of ASD worldwide is expected to boost the Autism Spectrum Disorder Therapeutics (ASD) therapeutics market growth. For instance, according to the data published in Our World in Data in 2017, around 62 million people worldwide were estimated to have ASD in 2016. Moreover, under 50 million of these cases were found in males. Of this 62 million with ASD, around 18 million had only Autism and 44 million had Asperger syndrome and other spectrum disorders.

However, stringent regulations and continuous watch employed by governing authorities for product approval and marketing of medicines can act as a potential hindrance for growth of the autism spectrum disorder therapeutics market. For instance, in May 2017, the U.S. Food and Drug Administration (FDA) shut down operations of Louisiana-based Pick and Pay Inc. Cili Minerals, a manufacturer of drug and dietary supplements, after finding that the company was falsely marketing products as being able to treat autism.

Key features of the study:

This report provides in-depth analysis of the autism spectrum disorder therapeutics market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2019 – 2027, considering 2018 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global autism spectrum disorder therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include, F. Hoffmann-La Roche AG, Neurim Pharmaceuticals, Inc., Yamo Pharmaceuticals LLC, Servier Laboratories Ltd., Otsuka Holdings Co. Ltd., Curemark LLC, Oryzon Genomics S.A., GW Pharmaceuticals Plc., Teva Pharmaceutical Industries Ltd., Zynerba Pharmaceuticals Inc., Stalicla SA., Novartis AG, Pfizer, Inc., and Bristol Myers Squibb
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global autism spectrum disorder therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for Autism Spectrum Disorder Therapeutics market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Autism Spectrum Disorder Therapeutics Market, By Drug Type:
- Aripiprazole
- Risperidone
- Melatonin
- CM-AT
- Bumetanide
- Balovaptan
Global Autism Spectrum Disorder Therapeutics Market, By Age Group:
- Child
- Adult
Global Autism Spectrum Disorder Therapeutics Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Autism Spectrum Disorder Therapeutics Market, By Region:
- North America
  - By Country:
    - U.S.
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - Canada
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
- Europe
  - By Country:
    - U.K.
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - Germany
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - Italy
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - Spain
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - France
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - Russia
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - Rest of Europe
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
- Asia Pacific
  - By Country:
    - China
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - Japan
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - India
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - ASEAN
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - Australia
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - South Korea
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - Rest of Asia Pacific
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
- Latin America
  - By Country:
    - Brazil
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - Mexico
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - Argentina
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - Rest of Latin America
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
- Middle East
  - By Country:
    - GCC
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - Israel
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - Rest of Middle East
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
- Africa
  - By Country/Region:
    - South Africa
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - Central Africa
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
    - North Africa
      - By Drug Type:
        
        Aripiprazole
        
        Risperidone
        
        Melatonin
        
        CM-AT
        
        Bumetanide
        
        Balovaptan
      - By Age Group:
        
        Child
        
        Adult
      - By Distribution Channel:
        
        Hospital Pharmacies
        
        Retail Pharmacies
        
        Online Pharmacies
Company Profiles
- F. Hoffmann-La Roche AG.*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Neurim Pharmaceuticals, Inc.
- Yamo Pharmaceuticals LLC
- Servier Laboratories Ltd.
- Otsuka Holdings Co. Ltd.
- Curemark LLC
- Oryzon Genomics S.A.
- GW Pharmaceuticals Plc.
- Teva Pharmaceutical Industries Ltd.
- Zynerba Pharmaceuticals Inc.
- Stalicla SA.
- Novartis AG
- Pfizer, Inc.
- Bristol Myers Squibb.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Drug Type
  - Market Snippet, By Age Group
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Landscape
- Collaborations & Partnerships
- Epidemiology Analysis
- Pipeline Analysis & Approved Product Analysis
- Regulatory Scenario
- Reimbursement Scenario
Global Autism Spectrum Disorder Therapeutics Market, By Drug Class, 2016 – 2027, (US$ Million)
- Introduction
  - Market Share Analysis, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Aripiprazole
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Risperidone
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Melatonin
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- CM-AT
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Bumetanide
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Balovaptan
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Global Autism Spectrum Disorder Therapeutics Market, By Age Group, 2016 – 2027, (US$ Million)
- Introduction
  - Market Share Analysis, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Child
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Adult
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Global Autism Spectrum Disorder Therapeutics Market, By Distribution Channel, 2016 – 2027, (US$ Million)
- Introduction
  - Market Share Analysis, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Global Autism Spectrum Disorder Therapeutics Market, By Region, 2016 – 2027, (US$ Million)
- Introduction
  - Market Share Analysis, By Region, 2019 and 2027 (%)
  - Y-o-Y Growth Analysis, By Region, 2017 – 2027
  - Regional Trends
- North America
  - Introduction
  - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
  - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - U.S.
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - Canada
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Europe
  - Introduction
  - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
  - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - U.K.
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - Germany
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - Italy
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - France
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - Spain
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - Russia
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - Rest of Europe
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Asia Pacific
  - Introduction
  - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
  - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - China
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - Japan
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - India
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - ASEAN
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - Australia
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - South Korea
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - Rest of Asia Pacific
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Latin America
  - Introduction
  - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
  - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - Brazil
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - Mexico
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - Argentina
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - Rest of Latin America
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Africa
  - Introduction
  - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
  - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
    - North Africa
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - Central Africa
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - South Africa
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
- Middle East
  - Introduction
  - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
  - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - GCC
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - Israel
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
    - Rest of Middle East
      - Market Size, Volume and Forecast, and Y-o-Y Growth, By Drug Class, 2016–2027, (US$ Mn, Units)
      - Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Million)
      - Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
Competitive Landscape
- Company Profiles
  - F. Hoffmann-La Roche AG
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Neurim Pharmaceuticals, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Yamo Pharmaceuticals LLC
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Servier Laboratories Ltd.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Otsuka Holdings Co. Ltd.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Curemark LLC
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Oryzon Genomics S.A.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - GW Pharmaceuticals Plc.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Teva Pharmaceutical Industries Ltd.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Zynerba Pharmaceuticals Inc.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - STALICLA SA
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Novartis AG
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Pfizer, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Bristol Myers Squibb
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
- Analyst Views
Section
- References
- Research Methodology
- About Us and Sales Contact

*Browse 146 market data tables and 30 figures on "Autism Spectrum Disorder Therapeutics Market” - Global forecast to 2027”

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

AUTISM SPECTRUM DISORDER THERAPEUTICS MARKET ANALYSIS

Autism Spectrum Disorder Therapeutics Market

Need a Custom Report?

EXISTING CLIENTELE